Redefining prostate cancer risk stratification: a pioneering strategy to estimate outcome based on Ki67 immunoscoring
Ângela Albuquerque-Castro(Universidade do Porto), Cármen Jerónimo(Universidade do Porto), Catarina Macedo‐Silva(University of Bern), Isa Carneiro(Instituto Português de Oncologia Francisco Gentil), João Lobo(Universidade do Porto), Vera Constâncio, Rúben Oliveira-Sousa(Universidade do Porto), Rui Henrique(Universidade do Porto)
Cited by 5
Related Papers
Integrative epigenetic taxonomy of primary prostate cancer
|Nature Communications|2018|167
Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic
|International Journal of Molecular Sciences|2019|141
Data Sharing Under the General Data Protection Regulation
|Hypertension|2021|136
Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours
|Nature Reviews Urology|2020|112
<scp>WHO</scp> 2022 landscape of papillary and chromophobe renal cell carcinoma
|Histopathology|2022|112